Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation-One-Year Survival.
Shmuel TiosanoAriel BanaiWesam MullaIdo GoldenbergGabriella BayshtokUri AmitNir ShlomoEyal NofRaphael RossoMichael GliksonVictor GuettaIsrael BarbashRoy BeinartPublished in: Journal of clinical medicine (2023)
In a pooled analysis of two registries, we found a significantly lower risk for 1-year mortality in patients with AF who were implanted with LAAO than those treated with NOACs. This finding was more prominent in patients with impaired renal function. Future prospective direct studies should further investigate the efficacy and adverse effects of both treatment strategies.
Keyphrases
- atrial fibrillation
- left atrial appendage
- oral anticoagulants
- catheter ablation
- left atrial
- direct oral anticoagulants
- heart failure
- cardiovascular events
- current status
- percutaneous coronary intervention
- risk factors
- free survival
- case control
- coronary artery disease
- newly diagnosed
- cardiovascular disease
- acute coronary syndrome
- venous thromboembolism
- emergency department
- mitral valve
- brain injury